Drug name - Nithiodote

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8496973 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(8 years from now)

US9345724 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(8 years from now)

US9585912 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(8 years from now)

US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(9 years from now)

EP3569237A1 HOPE PHARMS Sodium Nitrite-Containing Pharmaceutical Compositions
Feb, 2030

(7 years from now)

EP3569237B1 HOPE PHARMS Sodium Nitrite-Containing Pharmaceutical Compositions
Feb, 2030

(7 years from now)

EP2395834B1 HOPE PHARMS Sodium Nitrite-Containing Pharmaceutical Compositions
Feb, 2030

(7 years from now)

EP2395834A1 HOPE PHARMS Sodium Nitrite-Containing Pharmaceutical Compositions
Feb, 2030

(7 years from now)

EP2395834A4 HOPE PHARMS Sodium Nitrite-Containing Pharmaceutical Compositions
Feb, 2030

(7 years from now)

EP2451435B1 HOPE PHARMS Sodium Thiosulfate-Containing Pharmaceutical Compositions
Jul, 2030

(7 years from now)

EP2451435A4 HOPE PHARMS Sodium Thiosulfate-Containing Pharmaceutical Compositions
Jul, 2030

(7 years from now)

EP2451435A1 HOPE PHARMS Sodium Thiosulfate-Containing Pharmaceutical Compositions
Jul, 2030

(7 years from now)

EP2451435B2 HOPE PHARMS Sodium Thiosulfate-Containing Pharmaceutical Compositions
Jul, 2030

(7 years from now)

Drugs and Companies using SODIUM NITRITE; SODIUM THIOSULFATE ingredient

Treatment: NA

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML(250MG/ML) SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.